These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25044099)

  • 1. The clopidogrel conundrum.
    Bertino JS
    J Clin Pharmacol; 2014 Aug; 54(8):841-2. PubMed ID: 25044099
    [No Abstract]   [Full Text] [Related]  

  • 2. Clopidogrel, CYP2C19 and proton pump inhibitors: what we know and what it means.
    Hariharan S; Southworth MR; Madabushi R
    J Clin Pharmacol; 2014 Aug; 54(8):884-8. PubMed ID: 25044100
    [No Abstract]   [Full Text] [Related]  

  • 3. Changes in CYP2C19 enzyme activity evaluated by the [(13)C]-pantoprazole breath test after co-administration of clopidogrel and proton pump inhibitors following percutaneous coronary intervention and correlation to platelet reactivity.
    Harvey A; Modak A; Déry U; Roy M; Rinfret S; Bertrand OF; Larose É; Rodés-Cabau J; Barbeau G; Gleeton O; Nguyen CM; Proulx G; Noël B; Roy L; Paradis JM; De Larochellière R; Déry JP
    J Breath Res; 2016 Jan; 10(1):017104. PubMed ID: 26815196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinically relevant interaction between clopidogrel and proton pump inhibitors].
    Alban S; Dingermann T; Griese N; Kämmerer W; Schubert-Zsilavecz M; Schulz M; Trenk D; Zagermann-Muncke P
    Pharm Unserer Zeit; 2009; 38(4):370-1. PubMed ID: 19572357
    [No Abstract]   [Full Text] [Related]  

  • 5. Esomeprazole with clopidogrel reduces peptic ulcer recurrence, compared with clopidogrel alone, in patients with atherosclerosis.
    Hsu PI; Lai KH; Liu CP
    Gastroenterology; 2011 Mar; 140(3):791-8. PubMed ID: 21144850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omeprazole, pantoprazole, and CYP2C19 effects on clopidogrel pharmacokinetic-pharmacodynamic relationships in stable coronary artery disease patients.
    Simon N; Finzi J; Cayla G; Montalescot G; Collet JP; Hulot JS
    Eur J Clin Pharmacol; 2015 Sep; 71(9):1059-66. PubMed ID: 26071277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug interaction: Clopidogrel and PPIs.
    Med Lett Drugs Ther; 2017 Feb; 59(1515):39-40. PubMed ID: 28222065
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of esomeprazole on platelet reactivity and clinical outcome according to CYP2C19 genotype in coronary heart disease patients during dual antiplatelet therapy.
    Hokimoto S; Akasaka T; Tabata N; Arima Y; Tsujita K; Sakamoto K; Kaikita K; Morita K; Kumagae N; Yamamoto E; Oniki K; Nakagawa K; Ogawa H
    Thromb Res; 2015 Jun; 135(6):1081-6. PubMed ID: 25891840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton pump inhibitors and clopidogrel.
    Gaglia MA; Waksman R
    Cardiovasc Ther; 2010 Jun; 28(3):169-76. PubMed ID: 20345494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omeprazole: a possible new candidate influencing the antiplatelet effect of clopidogrel.
    Gurbel PA; Lau WC; Tantry US
    J Am Coll Cardiol; 2008 Jan; 51(3):261-3. PubMed ID: 18206733
    [No Abstract]   [Full Text] [Related]  

  • 11. The clopidogrel-statin interaction.
    Tantry US; Jeong YH; Gurbel PA
    Circ J; 2014; 78(3):592-4. PubMed ID: 24521731
    [No Abstract]   [Full Text] [Related]  

  • 12. Proton pump inhibitor co-therapy with clopidogrel: is there GI benefit or cardiovascular harm?
    Laine L
    Gastroenterology; 2011 Mar; 140(3):769-72. PubMed ID: 21266209
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacogenetics of clopidogrel and its clinical significance].
    Panchenko EP; Komarov AL
    Kardiologiia; 2012; 52(9):44-52. PubMed ID: 23098546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel.
    Sibbing D; Morath T; Stegherr J; Braun S; Vogt W; Hadamitzky M; Schömig A; Kastrati A; von Beckerath N
    Thromb Haemost; 2009 Apr; 101(4):714-9. PubMed ID: 19350116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonresponders to clopidogrel: pharmacokinetics and interactions involved.
    Giorgi MA; Di Girolamo G; González CD
    Expert Opin Pharmacother; 2010 Oct; 11(14):2391-403. PubMed ID: 20828266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clopidogrel: what is a cardiologist to do?
    Ford NF
    J Clin Pharmacol; 2014 Aug; 54(8):881-3. PubMed ID: 24824921
    [No Abstract]   [Full Text] [Related]  

  • 17. [Safety and effectiveness of combining clopidogrel and proton pump inhibitors].
    Calderón Hernanz B; Pinteño Blanco M; Puigventos Latorre F; Martínez-López I
    Farm Hosp; 2009; 33(6):338-9. PubMed ID: 20038395
    [No Abstract]   [Full Text] [Related]  

  • 18. CYP2C19 genotype and proton pump inhibitors in clopidogrel-treated patients: does it take two to tango?
    O'Donoghue ML
    Circulation; 2011 Feb; 123(5):468-70. PubMed ID: 21262991
    [No Abstract]   [Full Text] [Related]  

  • 19. [Interaction between clopidogrel and proton pump inhibitors].
    Harmsze AM; de Boer A; Boot H; Deneer VH; Heringa M; Mol PG; Schalekamp T; Verduijn MM; Verheugt FW; le Comte M
    Ned Tijdschr Geneeskd; 2011; 155(28):A2442. PubMed ID: 21771377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clopidogrel and Genotyping.
    Ford NF
    J Invasive Cardiol; 2015 Aug; 27(8):E173-4. PubMed ID: 26232022
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.